Showing results (41-50 of 238) with videos related to

Sort By:
Pageof 24
Cancer|October 28, 2014
Management trends in stage I testicular seminoma: Impact of race, insurance status, and treatment facilityPhillip J Gray, Chun Chieh Lin, Helmneh Sineshaw, et al.
Cancer Reports (Hoboken, N.J.)|August 16, 2023
Disparities in testicular cancer incidence, mortality, and place of death trends from 1999 to 2020: A comprehensive cohort studyBeck O Gold, Anushka Ghosh, Saveli I Goldberg, et al.
JAMA Network Open|April 26, 2022
Association of Race With Receipt of Proton Beam Therapy for Patients With Newly Diagnosed Cancer in the US, 2004-2018Leticia M Nogueira, Helmneh M Sineshaw, Ahmedin Jemal, et al.
Seminars in Radiation Oncology|September 19, 2015
DNA Damage Response Assessments in Human Tumor Samples Provide Functional Biomarkers of RadiosensitivityHenning Willers, Liliana Gheorghiu, Qi Liu, et al.
Urologic Oncology|November 23, 2017
Clinical characteristics and outcomes of nonurothelial cell carcinoma of the bladder: Results from the National Cancer Data BaseTrevor J Royce, Chun C Lin, Phillip J Gray, et al.
Medical Physics|May 3, 2013
Maximizing the biological effect of proton dose delivered with scanned beams via inhomogeneous daily dose distributionsChuan Zeng, Drosoula Giantsoudi, Clemens Grassberger, et al.
Medical Physics|September 21, 2011
Evaluation of the dosimetric impact of interfractional anatomical variations on prostate proton therapy using daily in-room CT imagesYi Wang, Jason A Efstathiou, Gregory C Sharp, et al.
World Journal of Urology|November 4, 2006
Bladder-sparing approaches to invasive diseaseJason A Efstathiou, Anthony L Zietman, Donald S Kaufman, et al.
International Journal of Radiation Oncology, Biology, Physics|February 25, 2016
A Prospective Comparison of the Effects of Interfractional Variations on Proton Therapy and Intensity Modulated Radiation Therapy for Prostate CancerMaryam Moteabbed, Alexei Trofimov, Gregory C Sharp, et al.
International Journal of Radiation Oncology, Biology, Physics|February 12, 2008
Body mass index and prostate-specific antigen failure following brachytherapy for localized prostate cancerJason A Efstathiou, Rafi Y Skowronski, John J Coen, et al.
Pageof 24